The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.

Autor: Ferreira N; University of Nicosia, Department of Social Sciences, Nicosia, Cyprus. Electronic address: ferreira.n@unic.ac.cy., Mikocka-Walus A; Deakin University Geelong, School of Psychology, Melbourne, Victoria, Australia., van Tilburg MAL; Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC, USA; College of Pharmacy and Health Sciences, Campbell University, Buies Creek, NC, USA; School of Social Work, University of Washington, Seattle, WA, USA., Graff LA; Max Rady College of Medicine, University of Manitoba Winnipeg, Manitoba, Canada., Apputhurai P; Swinburne University of Technology, Melbourne, Victoria, Australia., Barreiro-de Acosta M; IBD Unit, University Hospital Santiago de Compostela, Spain., Bennebroek Evertsz F; Amsterdam University Medical Centers, the Netherlands., Burisch J; Gastrounit, Medical Division, Hvidovre University Hospital, Denmark., Lo B; Gastrounit, Medical Division, Hvidovre University Hospital, Denmark., Petrik M; University of Minnesota Medical School, USA., Trindade IA; University of Coimbra, Portugal; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden., Jedel S; Rush University Medical Center, USA., Moser G; Medical University of Vienna, Austria., Mokrowiecka A; Medical University of Lodz, Poland., Bernstein CN; Max Rady College of Medicine, University of Manitoba Winnipeg, Manitoba, Canada., Dumitrascu D; Iuliu Haţieganu University of Medicine and Pharmacy, Romania., Ford AC; Leeds Institute of Medical Research at St. James's, University of Leeds, UK; Leeds Gastroenterology Institute, Leeds Teaching Hospitals Trust, UK., Stengel A; Department of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany; Charité Center for Internal Medicine and Dermatology, Department for Psychosomatic Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 12203 Berlin, Germany., Gearry R; University of Otago, Christchurch, New Zealand., Knowles SR; Swinburne University of Technology, Melbourne, Victoria, Australia.
Jazyk: angličtina
Zdroj: Journal of psychosomatic research [J Psychosom Res] 2021 Sep; Vol. 148, pp. 110561. Date of Electronic Publication: 2021 Jun 29.
DOI: 10.1016/j.jpsychores.2021.110561
Abstrakt: Objective: The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and more generally on the well-being of those living with chronic GI conditions.
Methods: A longitudinal survey with three time points (baseline, 6-month, and 12-month) will be conducted online. Adult participants with GI disorders from multiple countries will be recruited via patient associations, social media advertising, utilizing snowball sampling. Participants will be invited to complete a battery of questionnaires including demographic and health parameters, and measures of gastrointestinal symptoms, fear of COVID-19, perceived impact of COVID-19, illness perceptions, coping, depression, anxiety, stress, catastrophizing, and quality of life, using validated measures where available. Statistical analyses will include univariate descriptive models, multivariate models utilizing regression, mediation, and moderation, and latent growth models.
Conclusions: This project may present novel information to the field of psychogastroenterology and may provide crucial information regarding the areas of impact for individuals with GI disorders during and following the pandemic. Further, this information can guide healthcare providers and patient associations on how to target support related to the pandemic mental health sequelae for these patients.
(Copyright © 2021 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE